You can plan a clinical trial meticulously but when you start a First-in-Human study prepare to be flexible!

Richmond Pharmacology has extensive experience of conducting First-in-Human clinical trials, including studies involving biologics, and we have a very experienced team on hand to help you. You can be sure we will rise to the occasion.

View Case Study

Data Management Case Study - April 09

Richmond Pharmacology has extensive experience in the conduct of intensive thorough QTc studies. We are proud to offer a dedicated, highly skilled team within an efficient and safe hospital environment, using state of the art technology.

View Case Study

Data Management Case Study - March 09

Timelines, Tight Timelines, And Even Tighter Timelines In A Phase I Environment.

View Case Study

The Richmond Pharmacology Japanese Team commits to a challenging study...and they deliver.

Richmond Pharmacology has extensive experience in the conduct of intensive thorough QTc studies. We are proud to offer a dedicated, highly skilled team within an efficient and safe hospital environment, using state of the art technology.

View Case Study

65 Subjects Vaccinated in 1 day

Recruitment can sometimes be a challenge, however the tighter the timelines and the larger the group required, the more Richmond Pharmacology rises to the challenge.

View Case Study

“I am very pleased with the Project Management of both studies undertaken on behalf of (blank) and any future studies we have to outsource will automatically be contracted to you.”

- Anonymous

“Many thanks for your time today, most impressed with the quality of the follow up to our enquiry.”

- Anonymous

“Please know that it has been an absolute pleasure collaborating with you and that I am most appreciative of the key contributions RPL has made to this project thus far. I hope I have the opportunity to work with RPL again in the very near future.”

- Anonymous

Latest news

A first of a kind trial in the fight against malaria

June 12, 2024
Richmond successfully recruits and enrols adults of sub-Saharan ancestry who all complete a first of its kind trial in the treatment of malaria.
Read more

Patient with rare bleeding disorder becomes first to test new treatment

May 22, 2024
The thousands of patients who participate in Richmond’s trials are helping to advance medical science and save lives and, in the process, some make history. In a film released today, one trial participant tells her story.
Read more

Events

AHA Hypertension Scientific Sessions 2024

5 - 8 September 2024
Dr. Jörg Taubel, CEO of Richmond Pharmacology, will be attending the Hypertension 2024 Scientific Sessions
View event